Identification of nicotinamide aminonaphthyridine compounds as potent RET kinase inhibitors and antitumor activities against RET rearranged lung adenocarcinoma-Reference-Cited by-同舟云学术

Identification of nicotinamide aminonaphthyridine compounds as potent RET kinase inhibitors and antitumor activities against RET rearranged lung adenocarcinoma

Published:2019-09 Issue: Volume:90 Page:103052
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Wang Modi,Naganna N.,Sintim Herman O.

Funder

Purdue Institute for Drug Discovery

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference28 articles.

1. Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2;Mole;Hum. Mol. Gen.,1993

2. Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes;Drilon;Nat. Rev. Clin. Oncol.,2017

3. Mechanisms of receptor tyrosine kinase activation in cancer;Du;Mol. Cancer,2018

4. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing;Ju;Genome Res.,2012

5. Targeting the RET pathway in thyroid cancer;Wells;Clin. Cancer Res.,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress of small-molecule of RET inhibitors against Non-small cell lung cancer;AAPS Open;2024-06-17

2. Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update;Expert Opinion on Therapeutic Patents;2024-04-02

3. Unraveling the Promise of RET Inhibitors in Precision Cancer Therapy by Targeting RET Mutations;Journal of Medicinal Chemistry;2024-03-14

4. Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors;Molecular Cancer Therapeutics;2023-04-18

5. Recent Advances in the Multistep Continuous Preparation of APIs and Fine Chemicals;Current Topics in Medicinal Chemistry;2023-04